Rome, Italy

Luisa Maria Migneco

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Luisa Maria Migneco: A Trailblazer in Pharmaceutical Innovations**

Introduction

Luisa Maria Migneco, an innovative inventor based in Rome, Italy, has made significant contributions to the field of pharmaceuticals. With a portfolio that includes three patents, she has focused her research on developing novel therapeutic agents with enhanced efficacy and safety profiles.

Latest Patents

Migneco's latest patents showcase her commitment to advancing medicine. One notable invention is the **17-alpha-substituted derivatives of estradiol with wound-healing activity**. This invention pertains to 17α-(5-hydroxy-C-hydrocarbyl)-1,3,5(10)-estratrien-3,17β-diol derivatives, which possess cicatrising activity suitable for topical application on wounds without significant systemic effects. The patent also details a process for synthesizing these derivatives through a chemical reaction involving 3-OR-protected estrone.

Another significant innovation is related to **taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives**. This invention concerns water-soluble taxanes, specifically paclitaxel and docetaxel, which are crucial for developing pharmaceutical compositions in oncology and treating autoimmune disorders. The patent further includes methods for synthesizing these taxanes either directly or indirectly via spacers.

Career Highlights

Throughout her career, Luisa Maria Migneco has worked with prominent pharmaceutical companies such as Fidia Farmaceutici S.p.A. and Euticals S.p.A. Her work at these organizations has allowed her to spearhead innovative projects and contribute to the development of new therapeutic solutions.

Collaborations

Migneco has collaborated with several notable professionals in her field, including Rinaldo Marini Bettolo and Gilda De Luca. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and facilitates groundbreaking research.

Conclusion

Luisa Maria Migneco continues to be a pioneering force in the pharmaceutical industry. Her inventive spirit and dedication to improving healthcare through innovative solutions underscore her remarkable career as an inventor. With her latest patents, she is set to make a lasting impact on the treatment of health conditions, especially in wound healing and oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…